INTRODUCTION
Schistosomiasis is an important public health issue in more than 70 countries around the world. About 600 million people are at risk to acquire the parasite and there are 200 million people infected worldwide 18 . Although this is an evitable and curable disease, the costs for the control are very high and progress on treatment is delayed by economical issues of undeveloped countries. In Brazil the parasitosis is caused by Schistosoma mansoni and in 1990 it was estimated that 30 million people were exposed to the infection and about three to four million infected 2, 18 . The major public health impact is caused by chronic infection leading to intestinal, liver and spleen involvement. The hepatosplenic form of the disease is the most relevant cause of morbidity and mortality in Schistosoma mansoni infection. This presentation occurs in up to 10 % of the infected patients and is characterized by periportal liver fibrosis and consequently portal hypertension, leading to the formation of collateral circulation and risk of bleeding due to esophageal varices rupture 1 .
Upper digestive bleeding from esophageal varices may occur in approximately 60 % of the patients 4, 7, 8, 10 . In Brazil, the annual mortality caused by schistosomiasis was estimated in 0.3 per 100.000 inhabitants and in the rural population the disease represents an important cause of death 2,9 . The majority of individuals affected by the disease are young, economically active and present a normal liver function. Hepatic failure is rare and, when present, is related to other concomitant diseases such as viral hepatitis or chronic alcohol abuse. Indeed, bleeding from esophageal varices rupture is an important cause of mortality in these patients being the most relevant disease complication 7, 10, 15, 17 . The objective of this study was to analyze clinical, epidemiological, laboratorial and endoscopic features of the population with schistosomal portal hypertension and history of upper digestive bleeding due to esophageal varices rupture treated in a tertiary university hospital.
METHODS
One hundred and fifty five patients with hepatosplenic form of schistosomiasis and history of upper digestive bleeding from esophageal varices rupture that were submitted to surgical treatment by azigo-portal discon-nection and splenectomy were studied between March 1989 and April 2000.
Diagnosis was based in epidemiologic, clinic and laboratorial data and confirmed by histologic evaluation.
Patients who had viral hepatitis or chronic alcohol abuse or those with histologic evidence of another hepatopathy were excluded from this study.
All patients had been previously submitted to the parasitosis treatment with oral oxamnique or praziquantel. Patients were evaluated on clinic and nutritional status, and the body mass index was calculated (body mass index between 20-25 Kg/m 2 was considered as normal). Clinical signs of liver failure as the presence of ascitis, jaundice, liver encephalopathy, spiders and palmar eritema were evaluated.
Bleeding episodes due to esophageal varices rupture were characterized by its frequency, number, presence or not of hemodinamic repercussion and the need of any therapeutic measure.
The following laboratorial tests were evaluated: complete blood account, serum AST, ALT, alkaline phosfatase and gammaglutamil transpeptidase, bilirubins, total protein and albumin and prothrombin activity and RNI.
All patients underwent upper digestive endoscopy to confirm the presence of esophageal varices that were evaluated by its number, location, caliber and presence of red spots. The occurrence of congestive gastropathy was analyzed as well. After endoscopy patients were classified according to Paquet´s classification ( Figure 1 ).
All patients were submitted to abdominal ultrasound for liver, spleen and portal system evaluation.
RESULTS
There were 93 male (60 %) and 62 (40 %) female patients with a mean age of 37.2 years (range: 15 to 75 years). The majority of patients (89.7 %) were migrants from the states of Bahia, Minas Gerais and Pernambuco (Table 1 ).
All patients were in good clinical conditions with no signs of liver failure. The body mass index varied from 17 to 30 (mean: 23 Kg/m 2 ). The spleen was palpable in 135 (87 %) patients.
The number of bleeding episodes varied from one to 15, mean of 2.8 and median of two episodes per patient. Among 108 patients who had more than one bleeding episode, the interval between the first and the second hemorrhagic episode was less than a year in 58.6 %.
Upper digestive bleeding leaded to hemodynamic instability in 75.5 % of the patients and blood transfusion was necessary in 112 (74.2 %). Transfusion volume varied from 1 to 20 blood packs with a mean of three units per patient.
Thirteen patients (8.6 %) needed the insertion of the Sengstaken-Blakemore balloon in order to stop bleeding while 83 patients (54.6 %) have received some kind of endoscopic treatment during the bleeding episode or as secondary prophylaxis. In 69 patients (45.4 %) bleeding stopped spontaneously.
One hundred and six patients (70 %) had hemoglobin below 12 g/dL, mean of 10.6 g/dL; 114 (75 %) leucocytes number below 4000 per mm 3 , mean of 3390 leucocytes/ mm3; 129 (86.5 %) platelets count below 140,000 per mm3, mean of 87000 per mm 3 . One hundred and twenty six patients (84.5 %) presented serum albumin higher than 3.5 g/dL, mean of 4.2 g/dL and 111 (85 %) had total serum bilirrubin levels up to 1,5 mg/dL, mean of 1,08 mg/dL. Patients with total bilirrubin levels higher than 1.5 mg/dL, had this increase due to indirect billirubins. Ninety seven patients had prothrombin activity higher than 60 % (74 %), mean of 68 %.
Eighty one patients (52.6%) had esophageal-gastric varices classified as grade IV, 60 (39 %) as grade III, nine (5.8 %) as grade II, two (1.3 %) as grade I and two (1.3 %) as grade 0. Twenty one patients (13.6 %) presented congestive gastropathy and 62 (40.3 %) signs of red spots.
Ultrasound evaluation showed suggestive signs of chronic liver disease with periportal fibrosis and portal hypertension with splenomegaly and collateral circulation in all patients.
DISCUSSION
In Brazil, mansonic schistosomiasis is an endemic disease, and according to the present study,was noticed that most of the patients (90.4 %) were migrants from the states of Bahia, Minas Gerais and Pernambuco.
Schistosomal infection can be treated with drugs such as praziquantel or oxamniquine, however in the advanced form of the disease, periportal liver fibrosis, collateral circulation and portal hypertension are irreversible 17, 19 . When the hepatosplenic form of the disease is established the use of these drugs are not efficient to avoid bleeding from esophageal varices rupture 16 . Upper digestive bleeding is the most feared complication in patients with schistosomiasis and is usually the first manifestation of the disease. The selected group in this study was composed by young individuals with mean age of 37.2 years old and all patients were in good clinical and nutritional conditions. Moreover no clinical or laboratory signs of liver failure were observed, reinforcing that patients with schistosomiasis have a preserved liver function. The only finding at physical examination is an enlarged spleen, another typical characteristic of the disease 17 . Laboratorial evaluation showed that most patients had anemia, thrombocytopenia and leucopenia. Anemia was probably related to previous digestive bleeding episodes, and in some patients, carencial anemia, due to low socioeconomic conditions. Thrombocytopenia as well as leuchopenia observed respectively in 86.5 % and 75 % of the patients may be due to the hypersplenism, a typical characteristic of hepatosplenic schistosomiasis, where platelets and leukocytes are kidnapped by the huge spleen 15 . Liver function laboratory tests such as albumin, bilirubins and prothrombin activity were within normal limits or slightly altered.
The presence of red spots and large esophageal varices are known as risk factors for varices rupture and bleeding. In our study, endoscopic data showed that 91.6 % of patients had medium and large varices and 40.3 % had red spots signs, showing the high risk of bleeding in this population.
Patients had a mean of 2.8 upper digestive bleeding episodes due to varices rupture before hospital admittance for surgical treatment and approximately 70 % had more than one bleeding episode, being the second one in less than one year from the first episode in 53.7 % of the patients. Hemodynamic instability was observed in 75.5 % and blood transfusion was necessary in 74.2 % of the cases. The bleeding caused by esophageal varices rupture is the most relevant disease complication, leading to high rates of morbidity and mortality 3, 4, 8, 10, 16, 17 . Considering the severity of previous bleeding episodes and the high recurrence rate in a short interval of time, moreover the high incidence of large esophageal varices and the presence of red spots, treatment should be aggressive to avoid bleeding recurrence. The majority of groups that lead with the disease employ esophagogastric devascularization (azigo-portal disconnection) and splenectomy as the preferred surgical treatment 5, 6, 8, 11, 14 .
CONCLUSIONS
Patients with schistosomal portal hypertension and history of upper digestive bleeding from esophageal varices are young individuals, without either clinical or laboratorial evidence of liver dysfunction, that present high morbidity due to the severity of the acute event of bleeding.
